Neuropsychopharmacology
Journal of Psychopharmacology
European Neuropsychopharmacology
Psychopharmacology
- Sodium butyrate ameliorates the cognitive impairment of Alzheimer’s disease by regulating the metabolism of astrocytes4 years ago
- Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review4 years ago
- Ketamine abrogates sensorimotor deficits and cytokine dysregulation in a chronic unpredictable mild stress model of depression4 years ago
- Effectiveness and safety of intravenous valproate in agitation: a systematic review4 years ago
- Abuse and dependence potential of sphingosine-1-phosphate (S1P) receptor modulators used in the treatment of multiple sclerosis: a review of literature and public data4 years ago
- 5-HT2C receptor perturbation has bidirectional influence over instrumental vigour and restraint4 years ago
- Comparative efficacy of mitochondrial agents for bipolar disorder during depressive episodes: a network meta-analysis using frequentist and Bayesian approaches4 years ago
International Journal of Neuropsychopharmacology
Frontiers in Pharmacology
Translational Psychiatry
Molecular Psychiatry
Nature Reviews Neuroscience
CNS Spectrum
Neuropharmacology
Nature
- Why evaluating the impact of AI needs to start now5 months ago
- Should we treat rivers as living things?5 months ago
- Meet the biotech-company founders driven by their child’s rare disease5 months ago
- Daily briefing: NASA staff speak out against Trump cuts5 months ago
- ‘We have less than ten minutes’: how I communicate with spacecraft from the ground5 months ago
- How your research can survive a US federal grant termination5 months ago
- Daily briefing: How the brain boots up from sleep to wakefulness5 months ago